Human locomotion involves a complex interplay among multiple brain regions and depends on constant feedback from the visual system. We summarize here the current understanding of the relationship among fixations, saccades, and gait as observed in studies sampling eye movements during locomotion, through a review of the literature and a synthesis of the relevant knowledge on the topic. A significant overlap in locomotor and saccadic neural circuitry exists that may support this relationship. Several animal studies have identified potential integration nodes between these overlapping circuitries. Behavioral studies that explored the relationship of saccadic and gait-related impairments in normal conditions and in various disease states are also discussed. Eye movements and locomotion share many underlying neural circuits, and further studies can leverage this interplay for diagnostic and therapeutic purposes.
Citations
Citations to this article as recorded by
New Insights into Freezing of Gait in Parkinson's Disease from Spectral Dynamic Causal Modeling Seira Taniguchi, Yuta Kajiyama, Takanori Kochiyama, Gajanan Revankar, Kotaro Ogawa, Emi Shirahata, Kana Asai, Chizu Saeki, Tatsuhiko Ozono, Yasuyoshi Kimura, Kensuke Ikenaka, Nicholas D'Cruz, Moran Gilat, Alice Nieuwboer, Hideki Mochizuki Movement Disorders.2024;[Epub] CrossRef
Effectiveness of eye movement exercise and diaphragmatic breathing with jogging in reducing migraine symptoms: A preliminary, randomized comparison trial Mohammad Dawood Rahimi, Pouriya Hassani, Mohammad Taghi Kheirkhah, Javad Salehi Fadardi Brain and Behavior.2023;[Epub] CrossRef
The frequency and characteristics of saccadic dysmetria in isolated cerebellar infarction Sohyeon Kim, Hyun Ah Kim, Hyung Lee Neurological Sciences.2023; 44(6): 2097. CrossRef
M2 Cortex Circuitry and Sensory-Induced Behavioral Alterations in Huntington's Disease: Role of Superior Colliculus Sara Conde-Berriozabal, Lia García-Gilabert, Esther García-García, Laia Sitjà-Roqueta, Xavier López-Gil, Emma Muñoz-Moreno, Mehdi Boutagouga Boudjadja, Guadalupe Soria, Manuel J Rodríguez, Jordi Alberch, Mercè Masana The Journal of Neuroscience.2023; 43(18): 3379. CrossRef
The Microsoft HoloLens 2 Provides Accurate Biomechanical Measures of Performance During Military-Relevant Activities in Healthy Adults Mandy Miller Koop, Anson B Rosenfeldt, Kelsey Owen, Eric Zimmerman, Joshua Johnston, Matthew C Streicher, Alec Albright, Amanda L Penko, Jay L Alberts Military Medicine.2023; 188(Supplement): 92. CrossRef
What Happens in Your Brain When You Walk Down the Street? Implications of Architectural Proportions, Biophilia, and Fractal Geometry for Urban Science Aenne A. Brielmann, Nir H. Buras, Nikos A. Salingaros, Richard P. Taylor Urban Science.2022; 6(1): 3. CrossRef
Decreased Saccadic Eye Movement Speed Correlates with Dynamic Balance in Older Adults Youngsook Bae International Journal of Environmental Research and Public Health.2022; 19(13): 7842. CrossRef
Effects of different virtual reality technology driven dual-tasking paradigms on posture and saccadic eye movements in healthy older adults Yu Imaoka, Andri Flury, Laura Hauri, Eling D. de Bruin Scientific Reports.2022;[Epub] CrossRef
Coordination between Eye Movement and Whisking in Head-Fixed Mice Navigating a Plus Maze Ronny Bergmann, Keisuke Sehara, Sina E. Dominiak, Jens Kremkow, Matthew E. Larkum, Robert N. S. Sachdev eneuro.2022; 9(4): ENEURO.0089-22.2022. CrossRef
Deep brain stimulation and eye movements Maja Klarendic, Diego Kaski European Journal of Neuroscience.2021; 53(7): 2344. CrossRef
Antisaccade, a predictive marker for freezing of gait in Parkinson’s disease and gait/gaze network connectivity Cécile Gallea, Benoit Wicki, Claire Ewenczyk, Sophie Rivaud-Péchoux, Lydia Yahia-Cherif, Pierre Pouget, Marie Vidailhet, Elodie Hainque Brain.2021; 144(2): 504. CrossRef
Response Inhibition Deficits in Women with the FMR1 Premutation are Associated with Age and Fall Risk Carly Moser, Lyndsay Schmitt, Joseph Schmidt, Amanda Fairchild, Jessica Klusek Brain and Cognition.2021; 148: 105675. CrossRef
Concomitant improvement in anti-saccade success rate and postural instability gait difficulty after rTMS treatment for Parkinson’s disease Ken-ichi Okada, Mizuki Takahira, Tomoo Mano, Taichi Uga, Kuni Konaka, Koichi Hosomi, Youichi Saitoh Scientific Reports.2021;[Epub] CrossRef
Multitasking Compensatory Saccadic Training Program for Hemianopia Patients: A New Approach With 3-Dimensional Real-World Objects Laura Mena-Garcia, Jose C. Pastor-Jimeno, Miguel J. Maldonado, Maria B. Coco-Martin, Itziar Fernandez, Juan F. Arenillas Translational Vision Science & Technology.2021; 10(2): 3. CrossRef
The Role of Binocular Vision in Avoiding Virtual Obstacles While Walking Jingbo Zhao, Robert S. Allison IEEE Transactions on Visualization and Computer Graphics.2021; 27(7): 3277. CrossRef
Saccade and Fixation Eye Movements During Walking in People With Mild Traumatic Brain Injury Ellen Lirani-Silva, Samuel Stuart, Lucy Parrington, Kody Campbell, Laurie King Frontiers in Bioengineering and Biotechnology.2021;[Epub] CrossRef
Multiple system atrophy (MSA) is an adult-onset, progressive neurodegenerative disorder. Patients with MSA show various phenotypes during the course of their illness, including parkinsonism, cerebellar ataxia, autonomic failure, and pyramidal signs. Patients with MSA sometimes present with isolated autonomic failure or motor symptoms/ signs. The median duration from onset to the concomitant appearance of motor and autonomic symptoms is approximately 2 years but can range up to 14 years. As the presence of both motor and autonomic symptoms is essential for the current diagnostic criteria, early diagnosis is difficult when patients present with isolated autonomic failure or motor symptoms/signs. In contrast, patients with MSA may show severe autonomic failure and die before the presentation of motor symptoms/signs, which are currently required for the diagnosis of MSA. Recent studies have also revealed that patients with MSA may show nonsupporting features of MSA such as dementia, hallucinations, and vertical gaze palsy. To establish early diagnostic criteria and clinically definitive categorization for the successful development of disease-modifying therapy or symptomatic interventions for MSA, research should focus on the isolated phase and atypical symptoms to develop specific clinical, imaging, and fluid biomarkers that satisfy the requirements for objectivity, for semi- or quantitative measurements, and for uncomplicated, worldwide availability. Several novel techniques, such as automated compartmentalization of the brain into multiple parcels for the quantification of gray and white matter volumes on an individual basis and the visualization of α-synuclein and other candidate serum and cerebrospinal fluid biomarkers, may be promising for the early and clinically definitive diagnosis of MSA.
Citations
Citations to this article as recorded by
Cranial Nerve Thinning Distinguishes RFC1‐Related Disorder from Other Late‐Onset Ataxias Camila C. Lobo, Guilherme S.O. Wertheimer, Gabriel S. Schmitt, Paula C.A.A.P. Matos, Thiago J.R. Rezende, Joyce M. Silva, Fabrício C. Borba, Fabrício D. Lima, Alberto R.M. Martinez, Orlando G.P. Barsottini, José Luiz Pedroso, Wilson Marques, Marcondes C. Movement Disorders Clinical Practice.2024; 11(1): 45. CrossRef
The potential of phosphorylated α‐synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy Toufik Abdul‐Rahman, Ranferi Eduardo Herrera‐Calderón, Arjun Ahluwalia, Andrew Awuah Wireko, Tomas Ferreira, Joecelyn Kirani Tan, Maximillian Wolfson, Shankhaneel Ghosh, Viktoriia Horbas, Vandana Garg, Asma Perveen, Marios Papadakis, Ghulam Md Ashraf, Ath CNS Neuroscience & Therapeutics.2024;[Epub] CrossRef
Data-Driven Subtypes of Multiple System Atrophy and Their Implications for Prognosis Cheng-Cheng Fan, Chao Han, Xue-Mei Wang, Jagadish K. Chhetri, Wei Mao, Er-He Xu, Shu-Ying Liu, Piu Chan Journal of Parkinson's Disease.2024; 14(6): 1211. CrossRef
The effect of continuous positive airway pressure (CPAP) on the quality of life in patients with multiple system atrophy Hee Jin Chang, Han-Joon Kim, Kyung Ah Woo, Jung Hwan Shin, Ki-Young Jung Sleep and Breathing.2023; 27(4): 1481. CrossRef
Psychosis treatment in a patient with Parkinsonian type multiple system atrophy using modified electroconvulsive therapy: a case report Takumi Yawata, Shunsuke Takagi, Takehiro Tamura, Genichi Sugihara, Hidehiko Takahashi Psychogeriatrics.2023; 23(2): 364. CrossRef
Comparison of the second consensus statement with the movement disorder society criteria for multiple system atrophy: A single-center analysis Yunchuang Sun, Wei Sun, Luhua Wei, Fan Li, Yanyan Jiang, Fei Zhai, Mingyue Luan, Jing Chen, Zhaoxia Wang Parkinsonism & Related Disorders.2023; 106: 105242. CrossRef
Multiple System Atrophy: Advances in Diagnosis and Therapy Hirohisa Watanabe, Sayuri Shima, Yasuaki Mizutani, Akihiro Ueda, Mizuki Ito Journal of Movement Disorders.2023; 16(1): 13. CrossRef
Multiple system atrophy-cerebellar: A case report and literature review Thi Thuong Doan, Thuy Dung Pham, Duy Duan Nguyen, Dac Hong An Ngo, Trong Binh Le, Thanh Thao Nguyen Radiology Case Reports.2023; 18(3): 1121. CrossRef
Hjerne med kors Linh Tran, Tuba Ahmad, Anniken Haslund, Phuoc Ngoc Thi Nguyen Tidsskrift for Den norske legeforening.2023;[Epub] CrossRef
α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies Noah J. Graves, Yann Gambin, Emma Sierecki International Journal of Molecular Sciences.2023; 24(15): 12134. CrossRef
A Rare Case of Cerebellar Ataxia Aanchal Arora, Nidhi Hooda, Jasneet Singh Channa, Motilal Negi Neurology India.2023; 71(5): 1031. CrossRef
Neurodegenerative disorders affecting the autonomic nervous system: Pure autonomic failure and multiple system atrophy Yoshitaka Yamanaka, Nobuyuki Araki, Satoshi Kuwabara Neurology and Clinical Neuroscience.2022; 10(3): 115. CrossRef
Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis Aurelija Jucaite, Zsolt Cselényi, William C. Kreisl, Eugenii A. Rabiner, Andrea Varrone, Richard E. Carson, Juha O. Rinne, Alicia Savage, Magnus Schou, Peter Johnström, Per Svenningsson, Olivier Rascol, Wassilios G. Meissner, Paolo Barone, Klaus Seppi, Ho Movement Disorders.2022; 37(1): 119. CrossRef
Data-driven subtype classification of patients with early-stage multiple system atrophy Hui-Jun Yang, Han-Joon Kim, Yu Jin Jung, Dallah Yoo, Ji-Hyun Choi, Jin Hee Im, Beomseok Jeon Parkinsonism & Related Disorders.2022; 95: 92. CrossRef
Clinicopathological correlates of pyramidal signs in multiple system atrophy Chi‐Ying R. Lin, Anisha Viswanathan, Tiffany X. Chen, Hiroshi Mitsumoto, Jean P. Vonsattel, Phyllis L. Faust, Sheng‐Han Kuo Annals of Clinical and Translational Neurology.2022; 9(7): 988. CrossRef
The “Black Straight-Line Sign” in the Putamen in Diffusion-Weighted Imaging: A Potential Diagnostic MRI Marker for Multiple System Atrophy Yiming Zheng, Xiwen Wang, Huajian Zhao, Yanyan Jiang, Ying Zhu, Jing Chen, Wei Sun, Zhaoxia Wang, Yunchuang Sun Frontiers in Neurology.2022;[Epub] CrossRef
Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism Hae-Won Shin, Sang-Wook Hong, Young Chul Youn Journal of Clinical Neurology.2022; 18(3): 259. CrossRef
Clinical Features and Neuroimaging Findings of Neuropil Antibody–Positive Idiopathic Sporadic Ataxia of Unknown Etiology Akira Takekoshi, Akio Kimura, Nobuaki Yoshikura, Isamu Yamakawa, Makoto Urushitani, Katsuya Nakamura, Kunihiro Yoshida, Takayoshi Shimohata The Cerebellum.2022; 22(5): 915. CrossRef
Determinants of cognitive impairment in multiple system atrophy: Clinical and genetic study Amina Nasri, Alya Gharbi, Ikram Sghaier, Saloua Mrabet, Amira Souissi, Amina Gargouri, Mouna Ben Djebara, Imen Kacem, Riadh Gouider, Tuhin Virmani PLOS ONE.2022; 17(12): e0277798. CrossRef
Management of balance problems in an elderly with multiple system atrophy with predominant cerebellar ataxia (MSA-C) and sick sinus syndrome Amber Eker, Pembe Hare Yıgıtoglu, Hamza Duygu, Ersin Tan Journal of Gerontology and Geriatrics.2021; 69(3): 208. CrossRef
Immunotherapies in Huntington's disease and α-Synucleinopathies Oluwaseun Fatoba, Yosuke Ohtake, Takahide Itokazu, Toshihide Yamashita Frontiers in Immunology.2020;[Epub] CrossRef
The Dysfunctional Autonomic Function and “Dysfunctional” Fatigue in Drug Naïve Parkinson’s Disease Jong Hyeon Ahn, Minkyeong Kim, Jun Kyu Mun, Yoonsu Cho, Ji Sun Kim, Jinyoung Youn, Joong-Seok Kim, Jin Whan Cho Journal of Parkinson's Disease.2020; 10(2): 605. CrossRef
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies Giovanni Palermo, Eleonora Del Prete, Ubaldo Bonuccelli, Roberto Ceravolo Journal of Neurology.2020; 267(12): 3444. CrossRef
Changes of Amide Proton Transfer Imaging in Multiple System Atrophy Parkinsonism Type Shuhua Li, Piu Chan, Chunmei Li, Haibo Chen, Min Chen, Wen Su, Kai Li, Na Lu, Lu Yu, Defa Chu, Pu-Yeh Wu Frontiers in Aging Neuroscience.2020;[Epub] CrossRef
Purva Rupeeyam of bhela indriya sthana-an explorative study Kshama Gupta, Prasad Mamidi International Journal of Complementary & Alternative Medicine.2020; 13(6): 228. CrossRef
A case of multiple system atrophy Jing Guo, Fuying Liu, Tingting Liu, Xin Zhang, Yong Luo Journal of International Medical Research.2019; 47(11): 5839. CrossRef
Objective Patients with Parkinson’s disease (PD) frequently experience depression associated with voice problems. Singing involves the use of similar muscles and the neural networks associated with vocal function and emotional response. The purpose of this study is to enhance vocal quality and depressive symptoms of patients with PD using individual singing program.
Methods The Individual Therapeutic Singing Program for PD (ITSP-PD) was conducted by a certified music therapist. In total, nine PD patients with a subjective voice problem or depression participated in 6 sessions over 2 weeks. We measured the Maximum Phonation Time (MPT) via the Praat test, the Voice Handicap Index (VHI), the Voice-Related Quality of Life (V-RQOL) and the Geriatric Depression Scale (GDS).
Results In total, 8 out of 9 patients completed all the sessions; 6 out of 8 patients participated in the follow-up test after 6 months. A statistically significant change in MPT (p = 0.011) was observed between the pre- and post-tests. The VHI (p = 0.035) and the GDS (p = 0.018) were significantly lower in the post-test. In the pre-, post-, and follow-up tests, the MPT (p = 0.030), V-RQOL (p = 0.008), and GDS (p = 0.009) were significantly changed.
Conclusion The ITSP-PD based on neurological singing therapy for PD showed therapeutic possibility for vocal function and depression in patients with PD. Our findings suggest the need for a randomized study to examine the continuing positive effects of the ITSP-PD over a longer period of time.
Citations
Citations to this article as recorded by
Functional data analysis of prosodic prominence in Parkinson’s disease: a pilot study Lauri Tavi, Nelly Penttilä Clinical Linguistics & Phonetics.2024; 38(1): 64. CrossRef
Awareness of Dysphagia-Related Complications and Risks and the Importance of Early Intervention in Patients with Parkinson’s Disease: A Qualitative Study Kaifeng Yao, Lihua Wang, Lihua Zhang, Aderito Seixas International Journal of Clinical Practice.2023; 2023: 1. CrossRef
Group singing improves both physical and psychological wellbeing in people with and without chronic health conditions: A narrative review Quinn Campbell, Sally Bodkin-Allen, Nicola Swain Journal of Health Psychology.2022; 27(8): 1897. CrossRef
Defining the Therapeutic Singing Voice: Further Examination of the Everyday Singing Practices of Music Therapists Martina C Bingham, Elizabeth K Schwartz, Anthony Meadows Music Therapy Perspectives.2022; 40(1): 3. CrossRef
Music affects functional brain connectivity and is effective in the treatment of neurological disorders Luisa Speranza, Salvatore Pulcrano, Carla Perrone-Capano, Umberto di Porzio, Floriana Volpicelli Reviews in the Neurosciences.2022; 33(7): 789. CrossRef
Acute effects of singing on cardiovascular biomarkers Kamila Somayaji, Mogen Frenkel, Luai Tabaza, Alexis Visotcky, Tanya Kruse Ruck, Ernest Kwesi Ofori, Michael E. Widlansky, Jacquelyn Kulinski Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef
Music Therapy and Parkinson’s Disease: A Systematic Review from 2015–2020 Manuel Joaquín Machado Sotomayor, Víctor Arufe-Giráldez, Gerardo Ruíz-Rico, Rubén Navarro-Patón International Journal of Environmental Research and Public Health.2021; 18(21): 11618. CrossRef
The use of music as an arts-based method in migrant health research: a scoping review protocol Fran Garry, Sylvia Murphy Tighe, Anne MacFarlane, Helen Phelan HRB Open Research.2020; 3: 75. CrossRef
Walking the thin white line – managing voice in the older adult Jacqui Allen, Anna Miles Speech, Language and Hearing.2019; 22(1): 25. CrossRef
Music Therapy and Music-Based Interventions for Movement Disorders Kerry Devlin, Jumana T. Alshaikh, Alexander Pantelyat Current Neurology and Neuroscience Reports.2019;[Epub] CrossRef
Objective
The inability to propel a bolus of food successfully from the posterior part of the oral cavity to the oropharynx is defined as transfer dysphagia. The present case series describes the varied presentation of transfer dysphagia due to focal dystonia and highlights the importance of early detection by following up on strong suspicions.
Methods
We describe seven cases of transfer dysphagia due to focal dystonia. Transfer dysphagia as a form of focal dystonia may appear as the sole presenting complaint or may present with other forms of focal dystonia.
Results
Four out of seven patients had pure transfer dysphagia and had previously been treated for functional dysphagia. A high index of suspicion, barium swallow including videofluoroscopy, associated dystonia in other parts of the body and response to drug therapy with trihexyphenidyl/tetrabenazine helped to confirm the diagnosis.
Conclusion
Awareness of these clinical presentations among neurologists and non-neurologists can facilitate an early diagnosis and prevent unnecessary investigations.
Citations
Citations to this article as recorded by
EXCESSIVE CRYING IN CHILDREN WITH CEREBRAL PALSY AND COMMUNICATION DEFICITS Nagabhushana Rao Potharaju GLOBAL JOURNAL FOR RESEARCH ANALYSIS.2022; : 25. CrossRef
Oro-Pharyngeal Dysphagia in Parkinson’s Disease and Related Movement Disorders Miseon Kwon, Jae-Hong Lee Journal of Movement Disorders.2019; 12(3): 152. CrossRef
Objective
Musculoskeletal problems are more common in patients with Parkinson’s disease (PD) than in normal elderly, but the impact of musculoskeletal problems on health-related quality of life (HRQoL) in patients with PD is unknown.
Methods
Four hundred consecutive patients with PD were enrolled for the evaluation of musculoskeletal problems and HRQoL. HRQoL was assessed by the 36-Item Short Form Health Survey, which comprised physical health and mental health.
Results
Of the total patients, 265 patients had musculoskeletal problems, and 135 patients did not have musculoskeletal problems. Patients with musculoskeletal problems reported lower levels of HRQoL in terms of physical health than did patients without musculoskeletal problems (p < 0.05). In women, all components of physical health were lower in patients with musculoskeletal problems than in patients without musculoskeletal problems (p < 0.05). Meanwhile, in men, only the bodily pain score of physical health was lower in patients with musculoskeletal problems than in patients without musculoskeletal problems. Mental health and physical health were negatively correlated with depression, Unified Parkinson’s Disease Rating Scale I & II scores, and pain severity from musculoskeletal problems, in that order (p < 0.01 for all).
Conclusion
These results suggest that musculoskeletal problems in patients with PD affect HRQoL significantly, mainly in terms of physical health rather than mental health and especially in women rather than men. Musculoskeletal problems should not be overlooked in the care of patients with PD.
Citations
Citations to this article as recorded by
Assessments scales for the evaluation of health-related quality of life in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a systematic review Maria Lucia Maiuolo, Roberto Giorgini, Maria Grazia Vaccaro, Alessio Facchin, Andrea Quattrone, Aldo Quattrone Frontiers in Psychology.2024;[Epub] CrossRef
Total knee arthroplasty in patients with Parkinson’s disease: A systematic review and meta-analysis protocol Guangchen Sun, Hui Yu, Jun Cui, Ming Li, Yuefang Ru Medicine.2022; 101(52): e32315. CrossRef
Quality of life of older adults in two contrasting neighbourhoods in Accra, Ghana Dominic A. Alaazi, Devidas Menon, Tania Stafinski, Stephen Hodgins, Gian Jhangri Social Science & Medicine.2021; 270: 113659. CrossRef
The Efficiency of Spa Rehabilitation in Chronic Ischemic Stroke Patients—Preliminary Reports Bogumiła Pniak, Justyna Leszczak, Jadwiga Kurczab, Aleksandra Krzemińska, Joanna Pięta, Agnieszka Plis, Ewelina Czenczek-Lewandowska, Agnieszka Guzik Brain Sciences.2021; 11(4): 501. CrossRef
Sex-specific effects of subthalamic nucleus stimulation on pain in Parkinson’s disease Olga Khazen, Marisa DiMarzio, Kelsey Platanitis, Heather C. Grimaudo, Maria Hancu, Miriam M. Shao, Michael D. Staudt, Lucy Maguire, Vishad V. Sukul, Jennifer Durphy, Era K. Hanspal, Octavian Adam, Eric Molho, Julie G. Pilitsis Journal of Neurosurgery.2021; 135(2): 629. CrossRef
An overview of pain in Parkinson's disease Yi-Cheng Tai, Chin-Hsien Lin Clinical Parkinsonism & Related Disorders.2020; 2: 1. CrossRef
Clinical Perspectives of Parkinson's Disease for Ophthalmologists, Otorhinolaryngologists, Cardiologists, Dentists, Gastroenterologists, Urologists, Physiatrists, and Psychiatrists Ji-Hyun Choi, Jong-Min Kim, Hee Kyung Yang, Hyo-Jung Lee, Cheol Min Shin, Seong Jin Jeong, Won-Seok Kim, Ji Won Han, In-Young Yoon, Yoo Sung Song, Yun Jung Bae Journal of Korean Medical Science.2020;[Epub] CrossRef
Parkinson's Disease Is Associated with Increased Complications, Readmission Rates, and Costs of Care after Total Hip Arthroplasty: A Matched-Cohort Analysis Simon Katz, Kevin B. Marchand, Rushabh M. Vakharia, Hiba Anis, Nipun Sodhi, Nicolas S. Piuzzi, Michael A. Mont, Martin W. Roche The Journal of Hip Surgery.2020; 4(03): 149. CrossRef
Chronic Pain Treatment Strategies in Parkinson’s Disease Amber Edinoff, Niro Sathivadivel, Timothy McBride, Allyson Parker, Chikezie Okeagu, Alan D. Kaye, Adam M. Kaye, Jessica S. Kaye, Rachel J. Kaye, Meeta M. Sheth, Omar Viswanath, Ivan Urits Neurology International.2020; 12(3): 61. CrossRef
Sex differences in the short-term and long-term effects of subthalamic nucleus stimulation in Parkinson's disease Ryul Kim, Dallah Yoo, Ji-Hyun Choi, Jung Hwan Shin, Sangmin Park, Han-Joon Kim, Sun Ha Paek, Beomseok Jeon Parkinsonism & Related Disorders.2019; 68: 73. CrossRef
Objective
Cognitive impairment is one of the nonmotor symptoms in Parkinson’s disease (PD), and olfactory dysfunction is used as a marker to detect premotor stages of PD. Serum uric acid (sUA) levels have been found to be a risk factor for PD. Our objective in this study was to examine whether sUA levels are associated with cognitive changes and olfactory dysfunction in early de novo PD patients.
Methods
The study participants included 196 de novo PD patients. We assessed cognitive function by the Korean versions of the Mini-Mental State Examination and the Montreal Cognitive Assessment and assessed olfactory function by the Korean version of the Sniffin’ Sticks test.
Results
The mean sUA level was 4.7 mg/dL and was significantly lower in women than in men. Cognitive scores were lower in women, suggesting that sUA levels were related to cognitive function. The olfactory functions were not related to sUA level but were clearly associated with cognitive scores. Olfactory threshold, odor discrimination, and odor identification were all significantly related to cognitive scores.
Conclusion
We conclude that lower sUA levels were associated with cognitive impairment, not olfactory dysfunction, in de novo PD patients. This finding suggests that UA is neuroprotective as an antioxidant in the cognitive function of PD patients.
Citations
Citations to this article as recorded by
Relationships between Serum Lipid, Uric Acid Levels and Mild Cognitive Impairment in Parkinson's Disease and Multiple System Atrophy Xiaoqiao Ren, Pan Wang, Hao Wu, Shuai Liu, Jinhong Zhang, Xiyu Li, Yong Ji, Zhihong Shi Journal of Integrative Neuroscience.2024;[Epub] CrossRef
Serum uric acid and Parkinson's disease: A systematic review and meta‐analysis Mohammad Balabandian, Sarvenaz Salahi, Behnaz Mahmoudvand, Mahla Esmaeilzadeh, Seyedeh Melika Hashemi, Fardin Nabizadeh Neurology and Clinical Neuroscience.2023; 11(6): 299. CrossRef
International consensus statement on allergy and rhinology: Olfaction Zara M. Patel, Eric H. Holbrook, Justin H. Turner, Nithin D. Adappa, Mark W. Albers, Aytug Altundag, Simone Appenzeller, Richard M. Costanzo, Ilona Croy, Greg E. Davis, Puya Dehgani‐Mobaraki, Richard L. Doty, Valerie B. Duffy, Bradley J. Goldstein, David International Forum of Allergy & Rhinology.2022; 12(4): 327. CrossRef
Association of serum uric acid and non-motor symptoms in Parkinson's disease Olanike A. Odeniyi, Oluwadamilola O. Ojo, Ifedayo Adeola Odeniyi, Njideka Ulunma Okubadejo Journal of Clinical Sciences.2022; 19(3): 104. CrossRef
A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease Per Borghammer, Mie Kristine Just, Jacob Horsager, Casper Skjærbæk, Anna Raunio, Eloise H. Kok, Sara Savola, Shigeo Murayama, Yuko Saito, Liisa Myllykangas, Nathalie Van Den Berge npj Parkinson's Disease.2022;[Epub] CrossRef
What substance P might tell us about the prognosis and mechanism of Parkinson's disease? Paola Tirassa, Tommaso Schirinzi, Marcello Raspa, Massimo Ralli, Antonio Greco, Antonella Polimeni, Roberta Possenti, Nicola Biagio Mercuri, Cinzia Severini Neuroscience & Biobehavioral Reviews.2021; 131: 899. CrossRef
Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis Per Borghammer, Nathalie Van Den Berge, Teus van Laar Journal of Parkinson's Disease.2019; 9(s2): S281. CrossRef
The current body of literature contains 5 reports of myotonic dystrophy (DM) with parkinsonism: 4 reports of DM type 2 and 1 report of clinically suspected DM type 1. To date, there have been no genetically proven cases of DM type 1 with parkinsonism. Here, we report the first case of genetically proven DM type 1 and parkinsonism that developed ahead of muscle symptoms with bilateral putaminal, presynaptic dopaminergic deficits on imaging. A 54-year-old female patient presented with bradykinesia, axial and bilateral limb rigidity, stooped posture, and hypomimia, which did not respond to levodopa. At age 56, she developed neck flexion weakness. Examination showed bilateral facial weakness, percussion and grip myotonia, and electromyography confirmed myotonic discharges. A genetic study of DM type 1 showed a DMPK mutation. At age 58, gait freezing, postural instability, and frequent falling developed and did not respond to increasing doses of levodopa. At age 59, the patient died from asphyxia.
Parkinsonism as an initial presentation of Creutzfeldt‐Jakob disease: A case report and review of literature Sahar Nikkhah Bahrami, Asal Sadat Karimi, Sepehr Khosravi, Mostafa Almasi‐Dooghaee Clinical Case Reports.2024;[Epub] CrossRef
Atypical and early symptoms of sporadic Creutzfeldt – Jakob disease: case series and review of the literature Grammatiki Katsikaki, Ioannis E. Dagklis, Petros Angelopoulos, Dimitrios Ntantos, Angeliki Prevezianou, Sevasti Bostantjopoulou International Journal of Neuroscience.2021; 131(9): 927. CrossRef
Review of Hereditary and Acquired Rare Choreas Daniel Martinez-Ramirez, Ruth H. Walker, Mayela Rodríguez-Violante, Emilia M. Gatto Tremor and Other Hyperkinetic Movements.2020;[Epub] CrossRef
A Case of Creutzfeldt-Jakob Disease Presented as Rapid Progressive Parkinsonism Yoonah Park, Chan-Nyeong Lee Dementia and Neurocognitive Disorders.2019; 18(4): 152. CrossRef